Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brodalumab for Vascular Inflammation in Psoriasis
NCT03478280Phase 4Unknown
- Sponsor
- Aarhus University Hospital
- Start
- Sep 2018
- Primary completion
- Mar 2020
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of brodalumab in psoriasis, sponsored by Aarhus University Hospital. Status: unknown.
02
Drugs
brodalumab
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT03478280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03478280.